Mavorixafor, CAS [[558447-26-0]]

Produktübersicht

• Artikelname: Mavorixafor, CAS [[558447-26-0]]
• Artikelnummer: BYT-ORB1296155
• Hersteller Artikelnummer: orb1296155
• Alternativnummer: BYT-ORB1296155-1, BYT-ORB1296155-1, BYT-ORB1296155-10, BYT-ORB1296155-100, BYT-ORB1296155-2, BYT-ORB1296155-25, BYT-ORB1296155-5, BYT-ORB1296155-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: CXCR4, CXCR, CXC chemokine receptors, AMD 070, AMD070, AMD-070, inhibit, Inhibitor, HIV, Mavorixafor, Human immunodeficiency virus

Produktbeschreibung

Mavorixafor (AMD-070) is a potent and selective CXCR4 antagonist with a 13 nM IC50 for receptor binding. It effectively blocks T-tropic HIV-1 replication in vitro, showing IC50 values of 1 nM and 9 nM in MT-4 cells and PBMCs, respectively. Its research applications extend to oncology and immunology, including studies on cancer metastasis and stem cell mobilization.

Produkteigenschaften

• Molekulargewicht: 349.47
• Reinheit: 98.56% (May vary between batches)
• CAS Nummer: [558447-26-0]
• Formel: C21H27N5
• Target-Kategorie: HIV Protease,CXCR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween-80+45% Saline:2 mg/mL (5.72 mM),H2O:< 1 mg/mL (insoluble or slightly soluble),Ethanol:44 mg/mL (125.9 mM),DMSO:44 mg/mL (125.9 mM)